Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals

Journal of Hypertension

Volumn 34, Issue 3, 2016, Pages 506-512

  Tanaka, Fumitaka ^a   Komi, Ryosuke ^a   Makita, Shinji ^a   Onoda, Toshiyuki ^a   Tanno, Kozo ^a   Ohsawa, Masaki ^a   Itai, Kazuyoshi ^a   Sakata, Kiyomi ^a   Omama, Shinichi ^a   Yoshida, Yuki ^a   Ogasawara, Kuniaki ^a   Ishibashi, Yasuhiro ^b   Kuribayashi, Toru ^c   Okayama, Akira ^d   Nakamura, Motoyuki ^a  

^a Department of Internal Medicine ^*  (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c IWATE UNIVERSITY   (Japan)

^d Research Institute of Strategy for Prevention   (Japan)

Author keywords

cardiovascular disease; follow up studies; microalbuminuria; mortality; nondiabetic; nonhypertensive

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CREATININE URINE LEVEL; DEATH; DIABETES MELLITUS; ELEVATED BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION; PRIORITY JOURNAL; URINE LEVEL; AGED; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; DEATH, SUDDEN, CARDIAC; HEART FAILURE; JAPAN; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STROKE;

ADULT; AGED; ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STROKE;

EID: 84957539547     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000809     Document Type: Article

References (46)

1. Deckert T, Yokoyama H, Mathiesen E, Ronn B, Jensen T, Feldt-Rasmussen B, et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 1996; 312:871-874.
2. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in noninsulin-dependent diabetes mellitus: A systematic overview of the literature. Arch Intern Med 1997; 157:1413-1418.
3. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
4. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16:1325-1333.
5. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13:745-753.
6. Cao JJ, Biggs ML, Barzilay J, Konen J, Psaty BM, Kuller L, et al. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: The Cardiovascular Health Study. Atherosclerosis 2008; 197:806-813.
7. Mlacak B, Jaksić Z, Vuletić S. Albuminuria, cardiovascular morbidity and mortality in diabetic and nondiabetic subjects in a rural general practice. Fam Pract 1999; 16:580-585.
8. Mann JF, Yi QL, Gerstein HC. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int Suppl 2004; 92:S59-62.
9. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Circulation 2002; 106:1777-1782.
10. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 375:2073-2081.
11. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, et al. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol 2013; 61:1626-1633.
12. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 2005; 112:969-975.
13. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis 2003; 42:466-473.
14. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47:962-967.
15. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
16. Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S. Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: The JPHC Study. Am J Hypertens 2009; 22:273-280.
17. Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, et al. Association between serum C-reactive protein levels and microalbuminuria: A population-based cross-sectional study in northern Iwate, Japan. Intern Med 2004; 43:919-925.
18. Omama S, Yoshida Y, Ogawa A, Onoda T, Okayama A. Differences in circadian variation of cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage by situation at onset. J Neurol Neurosurg Psychiatry 2006; 77:1345-1349.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971; 285:1441-1446.
20. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90:583-612.
21. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004; 44:1268-1275.
22. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al., Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
23. Ohsawa M, Itai K, Tanno K, Onoda T, Ogawa A, Nakamura M, et al. Cardiovascular risk factors in the Japanese northeastern rural population. Int J Cardiol 2009; 137:226-235.
24. Ruggenenti P, Porrini E, Motterlini N, Perna A, Ilieva AP, Iliev IP, et al., BENEDICT Study Investigators. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol 2012; 23:1717-1724.
25. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, et al., Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. Lancet 2012; 380:1662-1673.
26. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, et al., Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A metaanalysis. Lancet 2012; 380:1649-1661.
27. Tanaka S, Takase H, Dohi Y, Kimura G. The prevalence and characteristics of microalbuminuria in the general population: A crosssectional study. BMC Res Notes 2013; 6:256.
28. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994; 43:426-429.
29. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344:14-18.
30. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. Insulin resistance syndrome and endothelial damage: role of adipose tissue derived proinflammatory cytokines [Abstract]. Diabetologia 1997; 40:A305.
31. Chang Y, Yoo T, Ryu S, Huh BY, Cho BL, Sung E, et al. Abdominal obesity, systolic blood pressure, and microalbuminuria in normotensive and euglycemic Korean men. Int J Obes (Lond) 2006; 30:800-804.
32. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The cardiovascular health study. Am J Kidney Dis 2004; 44:25-34.
33. Katz DH, Selvaraj S, Aguilar FG, Martinez EE, Beussink L, Kim KY, et al. Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (Hyper GEN) study. Circulation 2014; 129:42-50.
34. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen B, Appleyard M, Jensen G. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk 1997; 4:121-125.
35. Cao JJ, Barzilay JI, Peterson D, Manolio TA, Psaty BM, Kuller L, et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health Study. Atherosclerosis 2006; 187:372-377.
36. KimCH, Kim HK, Park JY, Park HS, Hong SK, Park SW, et al. Association of microalbuminuria and atherosclerotic risk factors in nondiabetic subjects in Korea. Diabetes Res Clin Pract 1998; 40:191-199.
37. Lin J, Hu FB, Curhan GC. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol 2010; 5:836-843.
38. Sharma S, McFann K, Chonchol M, de Boer IH, Kendrick J. Association between dietary sodium and potassium intake with chronic kidney disease in US adults: A cross-sectional study. Am J Nephrol 2013; 37:526-533.
39. Hoy WE, White AV, Tipiloura B, Singh G, Sharma SK, Bloomfield H, et al. The multideterminant model of renal disease in a remote Australian Aboriginal population in the context of early life risk factors: lower birth weight, childhood poststreptococcal glomerulonephritis, and current body mass index influence levels of albumi. Clin Nephrol 2015; 83:75-81.
40. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK. Association of albuminuria and cancer incidence. J Am Soc Nephrol 2008; 19:992-998.
41. Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, Dekker JM, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19:617-624.
42. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16:952-958.
43. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: The Hisayama study. Stroke 2007; 38:2063-2069.
44. Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, et al. What has made the population of Japan healthy? Lancet 2011; 378:1094-1105.
45. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013; 36:1033-1046.
46. Arredondo A, Aviles R. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems. PLoS One 2015; 10:e0118611.